Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 6 February 1981:
Vol. 211. no. 4482, pp. 603 - 605
DOI: 10.1126/science.6256856
Prev | Table of Contents | Next

Articles

Science, Vol 211, Issue 4482, 603-605
Copyright © 1981 by American Association for the Advancement of Science

articles

Metkephamid, a systemically active analog of methionine enkephalin with potent opioid alpha-receptor activity

RC Frederickson, EL Smithwick, R Shuman, and KG Bemis

Metkephamid is an analog of methionine enkephalin that retains high affinity for the delta receptor and is a systemically active analgesic. Since it is at least 100 times more potent than morphine as an analgesic when placed directly into the lateral ventricles, and is 30 to 100 times more potent on the delta receptor and yet is roughly equipotent on the mu receptor in vitro, it is concluded that it probably produces analgesia by action on delta receptors as well as, or rather than, on mu receptors. It has less tendency to produce respiratory depression, tolerance, and physical dependence than standard analgesics, and it is presently undergoing clinical trial.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Endomorphin System and Its Evolving Neurophysiological Role.
J. Fichna, A. Janecka, J. Costentin, and J.-C. Do Rego (2007)
Pharmacol. Rev. 59, 88-123
   Abstract »    Full Text »    PDF »
Pharmacodynamic and Pharmacokinetic Characterization of Poly(Ethylene glycol) Conjugation to Met-Enkephalin Analog [D-Pen2,D-Pen5]-enkephalin (DPDPE).
K. A. Witt, J. D. Huber, R. D. Egleton, M. J. Roberts, M. D. Bentley, L. Guo, H. Wei, H. I. Yamamura, and T. P. Davis (2001)
J. Pharmacol. Exp. Ther. 298, 848-856
   Abstract »    Full Text »    PDF »
The delta -Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy.
R. M. Quock, T. H. Burkey, E. Varga, Y. Hosohata, K. Hosohata, S. M. Cowell, C. A. Slate, F. J. Ehlert, W. R. Roeske, and H. I. Yamamura (1999)
Pharmacol. Rev. 51, 503-532
   Abstract »    Full Text »    PDF »
Structure-Activity Relationships of a Series of [D-Ala2]Deltorphin I and II Analogues; in Vitro Blood-Brain Barrier Permeability and Stability.
S. A. Thomas, T. J. Abbruscato, V. S. Hau, T. J. Gillespie, J. Zsigo, V. J. Hruby, and T. P. Davis (1997)
J. Pharmacol. Exp. Ther. 281, 817-825
   Abstract »    Full Text »
Novel "Restoration of Function" Mutagenesis Strategy to Identify Amino Acids of the delta -Opioid Receptor Involved in Ligand Binding.
M.-C. Pepin, S. Y. Yue, E. Roberts, C. Wahlestedt, and P. Walker (1997)
J. Biol. Chem. 272, 9260-9267
   Abstract »    Full Text »    PDF »
The Entry of [D-Penicillamine2,5]Enkephalin into the Central Nervous System: Saturation Kinetics and Specificity.
S. A. Thomas, T. J. Abbruscato, V. J. Hruby, and T. P. Davis (1997)
J. Pharmacol. Exp. Ther. 280, 1235-1240
   Abstract »    Full Text »
Separation of morphine analgesia from physical dependence.
G. Ling, J. MacLeod, S Lee, S. Lockhart, and G. Pasternak (1984)
Science 226, 462-464
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)